Study reveals no significant differences by race/ethnicity or sex. (HealthDay News) — Slightly higher levels of cardiac biomarkers may predict an increased risk for incident cancer, according to a ...
Randomized phase III study of trastuzumab, paclitaxel, and carboplatin versus trastuzumab and paclitaxel in women with HER-2 overexpressing metastatic breast cancer: An update including survival ...
TUESDAY, July 1, 2025 (HealthDay News) -- Slightly higher levels of cardiac biomarkers may predict an increased risk for incident cancer, according to a study published online in the July issue of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results